Ligand profile
ZINC104179301
Virtual-screening candidate from ZINC.
Bound to: VK055_5121 — amino acid adenylation domain protein
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC104179301- UniProt (similar protein)
Q9Z4X6- Tanimoto
- 0.643
- Target protein
- VK055_5121
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 49.3
- −1 ≤ LogP ≤ 5 3.40
- MW ≤ 500 Da 257.4
- LogP ≤ 5 3.40
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 2
- Rotatable bonds ≤ 10 12
- TPSA ≤ 140 Ų 49.3
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCCCCCCCCCCCNC(=O)[C@H](C)OCCCCCCCCCCCCNC(=O)[C@H](C)O
InChI=1S/C15H31NO2/c1-3-4-5-6-7-8-9-10-11-12-13-16-15(18)14(2)17/h14,17H,3-13H2,1-2H3,(H,16,18)/t14-/m0/s1InChI=1S/C15H31NO2/c1-3-4-5-6-7-8-9-10-11-12-13-16-15(18)14(2)17/h14,17H,3-13H2,1-2H3,(H,16,18)/t14-/m0/s1
RXDLDIAVKHIASM-AWEZNQCLSA-NRXDLDIAVKHIASM-AWEZNQCLSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- 5FQ
- Homolog
- Q9Z4X6
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC104179301 →
- ZINC ZINC20 ZINC104179301 →
- UniProt UniProt Q9Z4X6 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC104179301”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_5121.
PDB 15
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 1
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).